Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Tirzepatide wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
5g daily of standardized rosehip powder (the dose used in the OA trials)
with-meals
Standardized rosehip powder (GOPO-standardized)
Once-weekly subcutaneous injection, started at 2.5 mg and escalated by 2.5 mg every 4 weeks to a maintenance dose of 5, 10, or 15 mg (per the prescribing physician and approved indication)
any
Once-weekly subcutaneous injection (Mounjaro / Zepbound)
3 weeks to 3 months
3-12 weeks
Throughout use
Weeks to months
Months (dose-escalated over ~20 weeks)
Weeks to months
Mostly during titration
Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients?--a meta-analysis of randomized controlled trials.
Osteoarthritis Cartilage (2008) · Meta analysis · n=287
Pooled three RCTs (287 patients, median 3-month duration)
A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial.
Scand J Rheumatol (2005) · Crossover · n=94
94 patients, randomized double-blind placebo-controlled crossover, 5g/day for 3 months
The clinical effectiveness of rosehip powder in patients with osteoarthritis. A systematic review.
MMW Fortschr Med (2007) · Systematic review
Systematic review of two double-blind RCTs (N=100 and 112, Jadad score 5)
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.
N Engl J Med (2021) · Rct · n=1879
Open-label 40-week phase-3 head-to-head RCT (SURPASS-2) in 1879 patients with type 2 diabetes, tirzepatide 5/10/15 mg vs semaglutide 1 mg
Tirzepatide Once Weekly for the Treatment of Obesity.
N Engl J Med (2022) · Rct · n=2539
72-week phase-3 double-blind RCT (SURMOUNT-1) in 2539 adults with obesity (without diabetes), tirzepatide 5/10/15 mg vs placebo
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.
N Engl J Med (2025) · Rct · n=751
Phase-3b open-label head-to-head RCT (SURMOUNT-5) in 751 adults with obesity but without diabetes, max-tolerated tirzepatide vs max-tolerated semaglutide
Tirzepatide has a higher evidence score (7.8/10 vs 5/10) and wins in 2 of 3 categories.
No known interactions between Rosehip and Tirzepatide have been documented in our database. However, always consult a healthcare provider before combining supplements.